DEPAKOTE Side Effects

6786884-0 | Abnormal Behaviour, Aggression, Convulsion, Dysarthria, Hyperammonaemia, Postictal State, Psychotic Disorder
on Jun 15, 2010 Male patient from UNITED STATES , weighting 299.3 lb, was diagnosed with convulsion, hiccups and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, convulsion, dysarthria, hyperammonaemia, postictal state, psychotic disorder (What is psychotic disorder?). Depakote dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), ZONISAMIDE (View Zonisamide Review and Zonisamide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), ABILIFY (View Abilify Review and Abilify Label ), TEGRETOL XR (High Dose) (View Tegretol-xr Review and Tegretol-xr Label ), TEGRETOL XR (Lowest Dose) (View Tegretol-xr Review and Tegretol-xr Label ). Patient was hospitalized.

6765533-1 | Product Substitution Issue, Tremor
Patient was taking Depakote (View Usage). Patient had the following side effects: product substitution issue, tremor on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 112.0 lb, . Depakote dosage: 125mg Spr 3 Bid Po.

6765119-9 | Product Substitution Issue, Vomiting
Adverse event was reported on Jun 09, 2010 by a Female patient taking Depakote (View Usage) (Dosage: Depakote Spr 125 Mg 5 Caps Po Bid Po) . Location: UNITED STATES , weighting 124.0 lb, After Depakote was administered, patient had the following side effects: product substitution issue, vomiting.

6764893-5 | Blood Thyroid Stimulating Hormone Decreased, Dementia, Fall, Feeling Abnormal, Renal Disorder
on Jun 01, 2010 Female patient from UNITED STATES , weighting 140.1 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), epilepsy (What is epilepsy?), insomnia, depression (What is depression?), pain (What is pain?), hypertension and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: blood thyroid stimulating hormone decreased, dementia (What is dementia?), fall (What is fall?), feeling abnormal, renal disorder. Depakote dosage: . During the same period patient was treated with THORAZINE (View Thorazine Review and Thorazine Label ), VALIUM (View Valium Review and Valium Label ), EFFEXOR (View Effexor Review and Effexor Label ), DARVOCET (View Darvocet Review and Darvocet Label ), DARVON (View Darvon Review and Darvon Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ). Patient was hospitalized.


6760526-2 | Dizziness, Motion Sickness, Nausea, Product Substitution Issue
on Jun 07, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient had the following side effects: dizziness (What is dizziness?), motion sickness (What is motion sickness?), nausea (What is nausea?), product substitution issue. Depakote dosage: 750mg Am And 1000 Mg Hs Oral. During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ).

6757076-6 | Altered State Of Consciousness, Loss Of Consciousness, Respiratory Depression
Patient was taking Depakote (View Usage). After Depakote was administered, patient had the following side effects: altered state of consciousness, loss of consciousness, respiratory depression on May 26, 2010 from FRANCE Additional patient health information: Male patient , 54 years of age, was diagnosed with psychiatric symptom and. Depakote dosage: Gastro-resistant Tablet. During the same period patient was treated with THERALENE (View Theralene Review and Theralene Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), LOXAPAC (Coated) (View Loxapac Review and Loxapac Label ), EFFEXOR (Modified-release) (View Effexor Review and Effexor Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

6756990-5 | Vitreous Haemorrhage
Adverse event was reported on May 27, 2010 by a Female patient taking Depakote (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: vitreous haemorrhage.

6754728-9 | Dyskinesia, Feeling Abnormal, Tremor, Weight Abnormal
on May 25, 2010 Male patient from UNITED STATES , 38 years of age, weighting 170.2 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient had the following side effects: dyskinesia, feeling abnormal, tremor, weight abnormal. Depakote dosage: . During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ), VARENICLINE (View Varenicline Review and Varenicline Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6754652-1 | Neutropenia
on May 27, 2010 Female patient from FRANCE , 71 years of age, was diagnosed with persecutory delusion and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: neutropenia. Depakote dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), VALPROATE SODIUM (Gastro-resistant Tablet, Oral, Daily) (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6752163-0 | Neutrophil Percentage Increased, Ovarian Granulosa-theca Cell Tumour, Peritonitis Sclerosing, Respiratory Distress, White Blood Cell Count Increased
Patient was taking Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil percentage increased, ovarian granulosa-theca cell tumour, peritonitis sclerosing, respiratory distress, white blood cell count increased on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 14 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Depakote dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6746059-8 | Erysipelas, Neutropenia
Adverse event was reported on May 18, 2010 by a Female patient taking Depakote (View Usage) (Dosage: ) was diagnosed with hiv test positive (What is hiv test positive?) and. Location: UNITED STATES , 42 years of age, weighting 145.5 lb, Patient had the following side effects: erysipelas, neutropenia. During the same period patient was treated with MARAVIROC (View Maraviroc Review and Maraviroc Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized and became disabled.

6726659-1 | Abnormal Dreams, Agitation, Bronchitis, Crying, Dizziness, Hallucination, Headache, Lung Disorder
on May 04, 2010 Female patient from UNITED STATES , 41 years of age, weighting 213.2 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), ex-tobacco user, anxiety (What is anxiety?) and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: abnormal dreams, agitation, bronchitis (What is bronchitis?), crying, dizziness (What is dizziness?), hallucination, headache (What is headache?), lung disorder. Depakote dosage: 1000 Mg In Am, 1500mg At Night. During the same period patient was treated with CHANTIX (Film-coated Tablet) (View Chantix Review and Chantix Label ), GEODON (Hard) (View Geodon Review and Geodon Label ), ABILIFY (5mg In Am, 10mg At Night) (View Abilify Review and Abilify Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), FLOVENT (View Flovent Review and Flovent Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6718306-X | Vitreous Haemorrhage
on May 06, 2010 Female patient from FRANCE , 62 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: vitreous haemorrhage. Depakote dosage: .

6714126-0 | Pleural Effusion
Patient was taking Depakote (View Usage). Patient had the following side effects: pleural effusion on Apr 29, 2010 from FRANCE Additional patient health information: Male patient , 36 years of age, . Depakote dosage: Gastro-resistant Tablet.

6708880-1 | Abnormal Behaviour, Aggression, Anger, Disturbance In Attention, Impulsive Behaviour, Increased Appetite, Initial Insomnia, Product Substitution Issue
Adverse event was reported on May 03, 2010 by a Male patient taking Depakote (View Usage) (Dosage: 500 Mg Po) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 246.5 lb, After Depakote was administered, patient had the following side effects: abnormal behaviour, aggression, anger, disturbance in attention, impulsive behaviour, increased appetite, initial insomnia, product substitution issue.

6708595-X | Abasia, Hyperammonaemia, Incontinence, Somnolence
on Apr 23, 2010 Male patient from FRANCE , 58 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, hyperammonaemia, incontinence, somnolence. Depakote dosage: . During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ). Patient was hospitalized.

6695425-8 | Product Substitution Issue, Somnolence
on Apr 22, 2010 Female patient from UNITED STATES , weighting 118.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), migraine (What is migraine?) and was treated with Depakote (View Usage). Patient had the following side effects: product substitution issue, somnolence. Depakote dosage: 750 Mg A.m.-p.m. Early '90s-2010.

6693137-8 | Coordination Abnormal, Hemiparesis
Patient was taking Depakote (View Usage). After Depakote was administered, patient had the following side effects: coordination abnormal, hemiparesis on Apr 13, 2010 from FRANCE Additional patient health information: Male patient , 56 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Depakote dosage: . During the same period patient was treated with ABILIFY (Daily) (View Abilify Review and Abilify Label ).

6690958-2 | Coordination Abnormal, Hyperammonaemia, Salivary Hypersecretion, Somnolence
Adverse event was reported on Apr 12, 2010 by a Male patient taking Depakote (View Usage) (Dosage: ) was diagnosed with convulsion, bipolar disorder (What is bipolar disorder?) and. Location: FRANCE , 28 years of age, Patient experienced the following unwanted or unexpected effects: coordination abnormal, hyperammonaemia, salivary hypersecretion, somnolence. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6689177-5 | Coordination Abnormal, Hyperammonaemia, Salivary Hypersecretion, Somnolence
on Apr 12, 2010 Male patient from FRANCE , 25 years of age, was diagnosed with convulsion, bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient had the following side effects: coordination abnormal, hyperammonaemia, salivary hypersecretion, somnolence. Depakote dosage: .

6687139-5 | Abdominal Pain, Colitis, Dehydration, Diarrhoea, Disseminated Intravascular Coagulation, Pancreatitis, Pseudocyst, Pyrexia, Thrombocytopenia
on Apr 09, 2010 Female patient from UNITED STATES , weighting 116.0 lb, was diagnosed with lennox-gastaut syndrome and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), colitis, dehydration, diarrhoea, disseminated intravascular coagulation, pancreatitis, pseudocyst, pyrexia, thrombocytopenia. Depakote dosage: . During the same period patient was treated with CLOBAZAM (View Clobazam Review and Clobazam Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), CORTEF (View Cortef Review and Cortef Label ), HYDROCORTISON (View Hydrocortison Review and Hydrocortison Label ), DIASTAT (View Diastat Review and Diastat Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ). Patient was hospitalized.

6682259-3 | Alopecia, Cough, Tremor
Patient was taking Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, cough, tremor on Apr 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 312.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), prophylaxis and. Depakote dosage: 500 Mg 2 X Day Oral. During the same period patient was treated with LISINOPRIL (2.5 Mg 1 X Day Oral) (View Lisinopril Review and Lisinopril Label ).

6676733-3 | Product Substitution Issue
Adverse event was reported on Apr 09, 2010 by a Female patient taking Depakote (View Usage) (Dosage: 125 Mg Tid (three Times Daily) Oral) was diagnosed with convulsion and. Location: UNITED STATES , weighting 20.00 lb, Patient had the following side effects: product substitution issue. Patient was hospitalized.

6667354-7 | Asthenia, Cellulitis, Glucose Tolerance Impaired, Listless, Oedema Peripheral, Pulmonary Thrombosis, Sedation, Vitamin D Decreased
on Mar 26, 2010 Female patient from UNITED STATES , weighting 220.2 lb, was diagnosed with schizoaffective disorder, vitamin supplementation, pain in extremity and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: asthenia, cellulitis (What is cellulitis?), glucose tolerance impaired, listless, oedema peripheral, pulmonary thrombosis, sedation, vitamin d decreased. Depakote dosage: 750mg In A.m. And 500mg X 2 Qhs Qhs. During the same period patient was treated with SEROQUEL (300 Mg Daily) (View Seroquel Review and Seroquel Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), ULTRAM (View Ultram Review and Ultram Label ), THERAPEUTIC (View Therapeutic Review and Therapeutic Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6664793-5 | Abdominal Pain, Dehydration, Dysuria, Pancreatitis Acute, Tachycardia, Vomiting
on Mar 23, 2010 Female patient from FRANCE , 28 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dehydration, dysuria, pancreatitis acute, tachycardia, vomiting. Depakote dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6663172-4 | Colectomy
Patient was taking Depakote (View Usage). Patient had the following side effects: colectomy on Mar 23, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Depakote dosage: . During the same period patient was treated with DEPAKOTE ER (View Depakote Er Review and Depakote Er Label ).

6659603-6 | Asthenia, Cellulitis, Glucose Tolerance Impaired, Listless, Oedema Peripheral, Pulmonary Thrombosis, Sedation, Vitamin D Decreased
Adverse event was reported on Mar 22, 2010 by a Female patient taking Depakote (View Usage) (Dosage: 750mg In A.m. And 500mg X 2 Qhs Qhs) was diagnosed with schizoaffective disorder, vitamin supplementation, pain in extremity and. Location: UNITED STATES , weighting 220.2 lb, After Depakote was administered, patient had the following side effects: asthenia, cellulitis (What is cellulitis?), glucose tolerance impaired, listless, oedema peripheral, pulmonary thrombosis, sedation, vitamin d decreased. During the same period patient was treated with SEROQUEL (300 Mg Daily) (View Seroquel Review and Seroquel Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), ULTRAM (View Ultram Review and Ultram Label ), THERAPEUTIC (View Therapeutic Review and Therapeutic Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6656946-7 | Alcohol Use, Coagulopathy, Headache, Jaundice, Malaise, Mental Status Changes, Nausea, Pyrexia
on Mar 29, 2010 Female patient from UNITED STATES , 26 years of age, weighting 235.9 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol use, coagulopathy, headache (What is headache?), jaundice (What is jaundice?), malaise, mental status changes, nausea (What is nausea?), pyrexia. Depakote dosage: 1000 Mg Daily Oral 047. Patient was hospitalized.

6654197-3 | Hypoacusis
on Mar 16, 2010 Female patient from FRANCE , 45 years of age, was treated with Depakote (View Usage). Patient had the following side effects: hypoacusis. Depakote dosage: .

6653185-0 | Abdominal Pain, Colitis, Dehydration, Diarrhoea, Disseminated Intravascular Coagulation, Pancreatitis, Pseudocyst, Pyrexia, Thrombocytopenia
Patient was taking Depakote (View Usage). After Depakote was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), colitis, dehydration, diarrhoea, disseminated intravascular coagulation, pancreatitis, pseudocyst, pyrexia, thrombocytopenia on Mar 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 116.0 lb, was diagnosed with lennox-gastaut syndrome and. Depakote dosage: . During the same period patient was treated with CLOBAZAM (View Clobazam Review and Clobazam Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), CORTEF (View Cortef Review and Cortef Label ), HYDROCORTISON (View Hydrocortison Review and Hydrocortison Label ), DIASTAT (View Diastat Review and Diastat Label ), NITROFURANTOIN (View Nitrofurantoin Review and Nitrofurantoin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6651764-8 | Surgery
Adverse event was reported on Mar 16, 2010 by a Female patient taking Depakote (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 157.0 lb, Patient experienced the following unwanted or unexpected effects: surgery (What is surgery?). During the same period patient was treated with CHANTIX (View Chantix Review and Chantix Label ), XANAX (View Xanax Review and Xanax Label ), LYRICA (View Lyrica Review and Lyrica Label ), METHADONE (View Methadone Review and Methadone Label ), LASIX (View Lasix Review and Lasix Label ), KLOR CON (View Klor-con Review and Klor-con Label ).

6651690-4 | Disability
on Mar 16, 2010 Male patient from UNITED STATES , weighting 180.2 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakote (View Usage). Patient had the following side effects: disability. Depakote dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ).

6646445-0 | Diabetes Mellitus, Feeling Abnormal, Hepatic Enzyme Abnormal, Incorrect Dose Administered, Nephrolithiasis
on Mar 22, 2010 Male patient from UNITED STATES , 56 years of age, weighting 180.0 lb, was diagnosed with bipolar i disorder and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: diabetes mellitus, feeling abnormal, hepatic enzyme abnormal, incorrect dose administered, nephrolithiasis. Depakote dosage: 250 Mg. 4 Times A Day.

6645652-0 | Coma, Incorrect Dose Administered, Loss Of Consciousness
Patient was taking Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: coma, incorrect dose administered, loss of consciousness on Mar 16, 2010 from BRAZIL Additional patient health information: Female patient , 16 years of age, weighting 163.1 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), insomnia and. Depakote dosage: 100 Tablets. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6645400-4 | Pancytopenia, Renal Failure
Adverse event was reported on Mar 10, 2010 by a Female patient taking Depakote (View Usage) (Dosage: Gastro-resistant Tablet) was diagnosed with psychotic disorder (What is psychotic disorder?), atrial fibrillation (What is atrial fibrillation?), gastroduodenal ulcer, infection (What is infection?) and. Location: FRANCE , 75 years of age, Patient had the following side effects: pancytopenia, renal failure. During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), NASALIDE (View Nasalide Review and Nasalide Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6640627-X | Convulsion
on Mar 09, 2010 Male patient from FRANCE , 27 years of age, was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: convulsion. Depakote dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ZOPLICONE (View Zoplicone Review and Zoplicone Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SODIUM VALPROATE (View Sodium Valproate Review and Sodium Valproate Label ).

6635567-6 | Aggression, Anxiety, Lethargy, Restlessness, Tremor
on Jan 21, 2010 Male patient from UNITED STATES , 36 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anxiety (What is anxiety?), lethargy, restlessness, tremor. Depakote dosage: . During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), RISPERDAL (View Risperdal Review and Risperdal Label ).

6635564-0 | Alopecia, Dysarthria, Dyspnoea, Electroencephalogram Abnormal, Headache, Loss Of Consciousness, Memory Impairment, Mydriasis
Patient was taking Depakote (View Usage). Patient had the following side effects: alopecia, dysarthria, dyspnoea, electroencephalogram abnormal, headache (What is headache?), loss of consciousness, memory impairment, mydriasis on Jan 26, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 169.2 lb, was diagnosed with convulsion and. Depakote dosage: . During the same period patient was treated with DEPAKOTE ER (View Depakote Er Review and Depakote Er Label ).

6635557-3 | Abdominal Pain, Abdominal Pain Upper, Diarrhoea, Hallucination, Hot Flush, Pallor, Rash Macular
Adverse event was reported on Jan 26, 2010 by a Male patient taking Depakote (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: UNITED STATES , weighting 64.06 lb, After Depakote was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, diarrhoea, hallucination, hot flush, pallor, rash macular. During the same period patient was treated with DEPAKOTE ER (View Depakote Er Review and Depakote Er Label ), VALIUM (Hs) (View Valium Review and Valium Label ), DIASET (View Diaset Review and Diaset Label ).

6635555-X | Weight Increased
on Dec 29, 2009 Male patient from , weighting 251.2 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: weight increased. Depakote dosage: .

6635554-8 | Contusion, Gingival Bleeding, Tooth Loss
on Jan 12, 2010 Male patient from UNITED STATES , weighting 203.2 lb, was diagnosed with schizoaffective disorder, hypertension, intraocular pressure increased, sleep apnoea syndrome and was treated with Depakote (View Usage). Patient had the following side effects: contusion, gingival bleeding, tooth loss. Depakote dosage: . During the same period patient was treated with DEPAKOTE ER (View Depakote Er Review and Depakote Er Label ), ABILIFY (View Abilify Review and Abilify Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), AVAPRO (View Avapro Review and Avapro Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ), PROVIGIL (View Provigil Review and Provigil Label ).

6635551-2 | Decreased Appetite, Fatigue, Somnolence, Speech Disorder
Patient was taking Depakote (View Usage). After Depakote was administered, patient had the following side effects: decreased appetite, fatigue, somnolence, speech disorder on Dec 16, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 115.1 lb, was diagnosed with anxiety (What is anxiety?) and. Depakote dosage: . During the same period patient was treated with HALDOL (View Haldol Review and Haldol Label ).

6635550-0 | Back Pain, Convulsion
Adverse event was reported on Feb 12, 2010 by a Female patient taking Depakote (View Usage) (Dosage: ) was diagnosed with convulsion, back pain (What is back pain?) and. Location: UNITED STATES , weighting 195.2 lb, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), convulsion. During the same period patient was treated with DEPAKOTE ER (2 In The Morning: 3 At Night) (View Depakote Er Review and Depakote Er Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), CALCIUM (Occasionally) (View Calcium Review and Calcium Label ).

6635547-0 | Convulsion
on Dec 21, 2009 Male patient from UNITED STATES , weighting 127.1 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Depakote (View Usage). Patient had the following side effects: convulsion. Depakote dosage: .

6635546-9 | Alopecia
on Jan 13, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: alopecia. Depakote dosage: .

6635539-1 | Rash Macular, Rash Papular
Patient was taking Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: rash macular, rash papular on Dec 11, 2009 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with diabetes mellitus and. Depakote dosage: . During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), INSULIN (View Insulin Review and Insulin Label ).

6635538-X | Fatigue, Headache, Hot Flush, Irritability, Unevaluable Event
Adverse event was reported on Dec 08, 2009 by a Male patient taking Depakote (View Usage) (Dosage: Unsure Of Strength) was diagnosed with head injury, headache (What is headache?) and. Location: UNITED STATES , weighting 195.2 lb, Patient had the following side effects: fatigue, headache (What is headache?), hot flush, irritability, unevaluable event.

6635535-4 | Bipolar Disorder
on Feb 23, 2010 Female patient from UNITED STATES , weighting 227.1 lb, was diagnosed with bipolar i disorder, depression (What is depression?), insomnia and was treated with Depakote (View Usage). After Depakote was administered, patient had the following side effects: bipolar disorder (What is bipolar disorder?). Depakote dosage: . During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

6635532-9 | Hallucination
on Feb 23, 2010 Male patient from UNITED STATES , 48 years of age, was treated with Depakote (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination. Depakote dosage: .

6635519-6 | Anger, Convulsion, Feeling Abnormal, Hypersomnia, Insomnia, Pollakiuria, Weight Decreased
Patient was taking Depakote (View Usage). Patient had the following side effects: anger, convulsion, feeling abnormal, hypersomnia, insomnia, pollakiuria, weight decreased on Feb 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 118.1 lb, was diagnosed with convulsion, nutritional support (What is nutritional support?), vitamin supplementation and. Depakote dosage: Low Dose In The Beginning. During the same period patient was treated with DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), SOY POWDER (View Soy Powder Review and Soy Powder Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ).